RAP-103 is an orally active CCR antagonist that effectively protects synapses by inhibiting and reversing cytoskeletal changes induced by PrPC/NOX signaling. RAP-103 is applicable for research in Alzheimers disease (AD).
Molecular Weight:
598.61
CAS Number:
[1337998-99-8]
Formula:
C25H38N6O11
Target:
CCR
* VAT and and shipping costs not included. Errors and price changes excepted
